Bioanalytical and Biomarker Development, Shire, Lexington, MA, USA.
Bioanalytical Sciences, Pfizer, Andover, MA, USA.
AAPS J. 2017 Dec 27;20(1):22. doi: 10.1208/s12248-017-0159-4.
The accuracy of reported sample results is contingent upon the quality of the assay calibration curve, and as such, calibration curves are critical components of ligand binding and other quantitative methods. Regulatory guidance and lead publications have defined many of the requirements for calibration curves which encompass design, acceptance criteria, and selection of a regression model. However, other important aspects such as preparation and editing guidelines have not been addressed by health authorities. The goal of this publication is to answer many of the commonly asked questions and to present a consensus and the shared views of members of the ligand binding assay (LBA) community on topics related to calibration curves with focus on providing recommendations for the preparation and editing of calibration curves.
报告样本结果的准确性取决于分析校准曲线的质量,因此,校准曲线是配体结合和其他定量方法的关键组成部分。监管指南和主要出版物已经定义了校准曲线的许多要求,包括设计、验收标准和回归模型的选择。然而,其他重要方面,如制备和编辑指南,尚未得到卫生当局的解决。本出版物的目的是回答许多常见问题,并提出配体结合分析(LBA)社区成员对与校准曲线相关主题的共识和共同看法,重点是为校准曲线的制备和编辑提供建议。